Boltz Bio Joins AAlphaBio-Led AI Drug Discovery Data Consortium
GabriCorso · x · 2026-07-22
Boltz Bio announced it is a founding member of a new data consortium organized by AAlphaBio. The consortium includes major pharmaceutical and AI design companies such as GSK, Cradle Bio, and Dyno Therapeutics to advance AI-driven drug discovery.
Related event: Boltz Bio Joins AI Drug Discovery Data Consortium(4 posts)→
More from Companies & People
- AfterQuery launches Data Partnerships, betting frontier models have exhausted public web data — ycombinator · 2026-10-27
- Economist Bharat Chandar named Research Director for AI Economics at Stanford Digital Economy Lab — RishiBommasani · 2026-10-27
- Latvia becomes 10th European country to approve Tesla's Supervised FSD — Polymarket · 2026-10-27
- OpenAI DevDay Berlin: Codex weekly active users up 20x since January — reach_vb · 2026-10-27
- Google DeepMind Frontier Computation team recruits PhD student researchers in London — PetarV_93 · 2026-10-27
- Aeon's former EVP: AI agents are the most impactful innovation of my lifetime — akumar · 2026-10-27